Mr. Di Vincenzo previously worked at Smith+Nephew where he was senior vice president and general manager of the U.S. advance wound management business, according to an Oct. 4 news release. Before that, he worked at Systagenix, Becton Dickinson and Roche Diagnostics.
“I’m thrilled to have him join this team as Neuromodulation moves into the era of personalized medicine with sensing technology,” Brett Wall, executive vice president and president of Medtronic’s neuroscience business, said in the release. “He will play a key role in advancing our capabilities in these areas while driving business execution in alignment with Medtronic’s focus on a performance-driven culture..”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.